# A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects

> **NCT03086382** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma S.P.R.L.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Lacosamide (LCM) tablet
- **DRUG:** Lacosamide (LCM) syrup

## Key facts

- **NCT ID:** NCT03086382
- **Lead sponsor:** UCB Biopharma S.P.R.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-27
- **Primary completion:** 2017-03-28
- **Final completion:** 2017-03-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086382, "A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03086382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*